Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
ALS ( (AU:ALQ) ) has issued an update.
ALS Limited announced a change in the director’s interest, with Malcolm Deane acquiring 146,884 Performance Rights under the company’s 2025 Long-Term Incentive Plan, following shareholder approval at the 2025 AGM. This acquisition increases Deane’s total holdings and reflects ALS’s commitment to aligning executive interests with company performance, potentially impacting stakeholder confidence and the company’s market positioning.
The most recent analyst rating on (AU:ALQ) stock is a Buy with a A$23.50 price target. To see the full list of analyst forecasts on ALS stock, see the AU:ALQ Stock Forecast page.
More about ALS
ALS Limited operates in the testing, inspection, and certification industry, providing a range of services to various sectors including environmental, food, pharmaceutical, and industrial markets. The company focuses on delivering high-quality analytical testing and laboratory services to ensure safety and compliance across multiple industries.
Average Trading Volume: 1,316,957
Technical Sentiment Signal: Buy
Current Market Cap: A$11.1B
For a thorough assessment of ALQ stock, go to TipRanks’ Stock Analysis page.